Skip to content

Prospective clinical observational study on the multifocal intraocular lens Asqelio™ Toric Trifocal Clear

Prospective clinical observational study on the multifocal intraocular lens Asqelio™ Toric Trifocal Clear - AST Vision

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035104
Enrollment
20
Registered
2024-10-01
Start date
2024-09-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H26.9

Interventions

Group 1: Intervention arm (implantation of a multifocal intraocular lens during a cataract surgery)

Sponsors

Universitätsmedizin Rostock, Klinik und Poliklinik für Augenheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: • The patient must be at least 45 years old • Presbyopia • Cataract • The patient wants to be independent of glasses for near and distance vision • The patient's lifestyle and expectations match multifocal IOL implantation • Suitable for bilateral implantation where a toric IOL must be implanted in at least one eye • The IOL power calculated for the patient must be within the available diopter range • Expected best corrected visual acuity after IOL implantation is 20/25 or better • No secondary surgery planned during the course of the study • Availability, willingness and sufficient cognitive awareness and physical ability to complete the examination procedures throughout the study period • Patients must provide written informed consent

Exclusion criteria

Exclusion criteria: • Preoperative corneal astigmatism less than 1.00 D in both eyes • Patients who do not give informed consent • Patients who do not understand the process of the study • Previous corneal surgery or trauma. • Irregular cornea (e.g. keratoconus) • Choroidal hemorrhage • Microphthalmos • Severe corneal dystrophy • Glaucoma in the medically controlled or medically controlled • Clinically significant macular changes • Serious eye disease as a side effect • Non-age related cataract • Severe atrophy of the optic nerve • Diabetic retinopathy • Proliferative diabetic retinopathy • Amblyopia • Extremely shallow anterior chamber • Severe chronic uveitis • Pregnant or breastfeeding women • Rubella • Mature/dense cataract complicating preoperative fundus examination • Previous retinal detachment • Concurrent participation in other drug or clinical device research • Need for further eye surgery during the study period

Design outcomes

Primary

MeasureTime frame
The main hypothesis is to investigate the rotational stability up to 3 months after implantation of the Asqelio™™ Trifocal IOL in cataract surgery and to evaluate the refractive results after implantation.

Secondary

MeasureTime frame
Efficacy of the Asqelio™ Trifocal Toric 3 months post-implantation

Countries

Germany

Contacts

Public ContactTobias Brockmann

Universitätsmedizin Rostock, Klinik und Poliklinik für Augenheilkunde

tobias.brockmann@med.uni-rostock.de+493814948555

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026